Bimiralisib Completed Phase 2 Trials for Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02249429Open-Label, Non Randomized Phase 2 Study With Safety Run-In